Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

Aspen Pharmacare Holdings Limited

Aspen Pharmacare is a global specialty and branded multinational pharmaceutical company that markets and manufactures a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets.

Metric
Company Name	Aspen Pharmacare Holdings Limited
Symbol	APN
MSH ID	COM:ASPENPHARMA
Market	STOCKS
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Country	ZA
Stage
Employee Count	8.61K
Website	aspenpharma.com
LinkedIn
Founders

Metric
Market Cap	57.42M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	2.48B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.08B
EBITDA	656.70M
Operating Income	388.34M
Net Income	244.39M
EPS	0.55
Diluted EPS	0.55
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.46
Operating Profit Margin	0.22
EBITDA Margin	0.26
Net Profit Margin	0.12
Return on Equity	0.11
Return on Assets	0.06
Return on Capital Employed	0.14

APN

COM:ASPENPHARMA

Aspen Pharmacare

Last Close

17,007.00

25/11 09:24

Market Cap

1.03B

Beta: -

Volume Today

230.19K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	14.95
P/B Ratio	1.01
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.02
EV Multiple	5.89

Metric
Days Sales Outstanding
Days Payables Outstanding	66.54
Days Inventory Outstanding	295.43
Operating Cycle	303.18
Cash Conversion Cycle	212.42
Asset Turnover	0.55

Metric
Operating Cash Flow	345.44M
Free Cash Flow	38.29M
Cash Flow to Debt	0.31
Operating Cash Flow/Sales	0.15
Free Cash Flow Yield	0.04

Metric
Cash & Equivalents	684.61M
Accounts Receivable
Inventory	998.97M
Goodwill	303.10M
Debt to Capitalization	0.30
Debt to Assets	0.22
Current Ratio	1.92
Quick Ratio	1.09

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00
R&D to Revenue	0.01
SG&A to Revenue	0.10